Total Cancer Care Protocol: A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorNew Mexico Cancer Research Alliance
About this trial
The overall objective of this study is to ultimately develop an improved standard of cancer care by facilitating new cancer research, clinical trials, new technology, new informatics solutions, and "personalized medicine" for the University of New Mexico Comprehensive Cancer Center (UNMCCC) and the Oncology Research Information Exchange Network (ORIEN) Consortium of academic medical centers, community hospital systems, and other health care providers. To bring new translational research to the community, the ORIEN consortium has initiated the ORIEN Total Cancer Care Program (TCCP). The TCCP establishes a unique collection of blood, tissue, other biological samples and their associated data (survey data, medical records data, cancer registry data, and other related data) from thousands of patients with cancer or at risk of having cancer. This is not a treatment trial. It is a study designed to create a centralized data and tissue repository.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
18 years of age and older.
Has a diagnosis of cancer or is suspected of having cancer.
Able to understand and sign the Informed Consent form directly.
Pregnant women are permitted to be enrolled.
Disqualifiers
Prisoners
Trial population
Patients 18 years of age or older who have cancer or are at risk of developing cancer.
Trial design
Design model
Other
Time perspective
Prospective
Treatments tested in this trial
Biological specimen collection
Other interventionCollection of blood, tissue, other biological samples and their associated data (survey data, medical records data, cancer registry data, and other related data) from patients with cancer or at risk of having cancer. This is not a treatment trial. It is a study designed to create a centralized data and tissue repository.
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
Amount of clinical patient demographic data collected for a repository linked to clinical data for long-term research use.
Establish a longitudinal clinical data repository that will contain information about patient demographics collected via surveys and questionnaires.
Time frame
up to 20 years2
Amount of clinical patient medical treatment and outcome data collected via medical histories for long-term research use
Establish a longitudinal clinical data repository that will contain information about medical treatments and patient outcomes collected via medical chart review and patient medical histories.
Time frame
up to 20 years3
Number of biospecimens collected for a tissue repository linked to clinical data for long-term research use
Establish a longitudinal tissue repository that will contain tissues (blood, tumor tissue) and other biological samples and associated clinical data collected from consenting patients.
Time frame
up to 20 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
New Mexico Cancer Research Alliance
Lead sponsor
H. Lee Moffitt Cancer Center and Research Institute
Collaborator
Ohio State University Comprehensive Cancer Center
Collaborator
Source ClinicalTrials.gov